CD8A and neoplasm: OX40 has been shown to regulate tumor immunity as a member of the tumor necrosis factor superfamily and is highly expressed by activated CD4, CD8 T-cells and regulatory T-cells (Tregs) and to a lesser extent by neutrophils and natural killer (NK) cells.